Joseph C. Glorioso, Ph.D. - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Gene Therapy, Herpes simplex virus, Chronic Pain

271 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Glorioso JC, Cohen JB, Carlisle DL, Munoz-Sanjuan I, Friedlander RM. Moving toward a gene therapy for Huntington's disease. Gene Therapy. 22: 931-933. PMID 26633828 DOI: 10.1038/gt.2015.102  0.56
2015 Han J, Chu J, Keung Chan W, Zhang J, Wang Y, Cohen JB, Victor A, Meisen WH, Kim SH, Grandi P, Wang QE, He X, Nakano I, Chiocca EA, Glorioso Iii JC, et al. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells. Scientific Reports. 5: 11483. PMID 26155832 DOI: 10.1038/srep11483  0.56
2015 Guedon JM, Wu S, Zheng X, Churchill CC, Glorioso JC, Liu CH, Liu S, Vulchanova L, Bekker A, Tao YX, Kinchington PR, Goins WF, Fairbanks CA, Hao S. Current gene therapy using viral vectors for chronic pain. Molecular Pain. 11: 27. PMID 25962909 DOI: 10.1186/s12990-015-0018-1  0.56
2015 Mazzacurati L, Marzulli M, Reinhart B, Miyagawa Y, Uchida H, Goins WF, Li A, Kaur B, Caligiuri M, Cripe T, Chiocca EA, Chiocca N, Amankulor N, Cohen JB, Glorioso JC, et al. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 99-107. PMID 25200130 DOI: 10.1038/mt.2014.177  0.56
2014 Guedon JM, Zhang M, Glorioso JC, Goins WF, Kinchington PR. Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin. Gene Therapy. 21: 694-702. PMID 24830437 DOI: 10.1038/gt.2014.43  0.56
2014 Goins WF, Huang S, Cohen JB, Glorioso JC. Engineering HSV-1 vectors for gene therapy. Methods in Molecular Biology (Clifton, N.J.). 1144: 63-79. PMID 24671677 DOI: 10.1007/978-1-4939-0428-0_5  0.56
2014 Glorioso JC. Herpes simplex viral vectors: late bloomers with big potential. Human Gene Therapy. 25: 83-91. PMID 24502405 DOI: 10.1089/hum.2014.2501  0.56
2013 Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, Vandenberghe LH, Wilson TJ, Wolfe JH, Glorioso JC. Progress in gene therapy for neurological disorders. Nature Reviews. Neurology. 9: 277-91. PMID 23609618 DOI: 10.1038/nrneurol.2013.56  0.56
2013 Yokoyama H, Oguchi T, Goins WF, Goss JR, Nishizawa O, de Groat WC, Wolfe D, Krisky DM, Glorioso JC, Yoshimura N. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception. Human Gene Therapy. 24: 170-80. PMID 23316929 DOI: 10.1089/hum.2011.180  0.56
2013 Wang PY, Currier MA, Hansford L, Kaplan D, Chiocca EA, Uchida H, Goins WF, Cohen JB, Glorioso JC, van Kuppevelt TH, Mo X, Cripe TP. Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV. Gene Therapy. 20: 761-9. PMID 23254370 DOI: 10.1038/gt.2012.93  0.56
2013 Funahashi Y, Oguchi T, Goins WF, Gotoh M, Tyagi P, Goss JR, Glorioso JC, Yoshimura N. Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats. The Journal of Urology. 189: 366-73. PMID 23174234 DOI: 10.1016/j.juro.2012.08.192  0.56
2013 Uchida H, Chan J, Shrivastava I, Reinhart B, Grandi P, Glorioso JC, Cohen JB. Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread. Journal of Virology. 87: 1430-42. PMID 23152509 DOI: 10.1128/JVI.02804-12  0.56
2013 Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, ... ... Glorioso JC, et al. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9. PMID 23070115 DOI: 10.1038/mt.2012.211  0.56
2013 Oguchi T, Funahashi Y, Yokoyama H, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Yoshimura N. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception. Gene Therapy. 20: 194-200. PMID 22402319 DOI: 10.1038/gt.2012.24  0.56
2012 Reinhart B, Mazzacurati L, Forero A, Hong CS, Eguchi J, Okada H, Fellows W, Niranjan A, Cohen JB, Glorioso JC, Grandi P. Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. Advances in Virology. 2012: 815465. PMID 22924042 DOI: 10.1155/2012/815465  0.56
2012 Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41. PMID 22753591 DOI: 10.1158/1078-0432.CCR-12-0697  0.56
2012 Goins WF, Cohen JB, Glorioso JC. Gene therapy for the treatment of chronic peripheral nervous system pain. Neurobiology of Disease. 48: 255-70. PMID 22668775 DOI: 10.1016/j.nbd.2012.05.005  0.56
2012 Zhu X, McTiernan CF, Rajagopalan N, Shah H, Fischer D, Toyoda Y, Letts D, Bortinger J, Gibson G, Xiang W, McCurry K, Mathier M, Glorioso JC, London B. Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression. Human Gene Therapy. 23: 722-32. PMID 22482463 DOI: 10.1089/hum.2011.108  0.56
2012 Salerno KM, Jing X, Diges CM, Cornuet PK, Glorioso JC, Albers KM. Sox11 modulates brain-derived neurotrophic factor expression in an exon promoter-specific manner. Journal of Neuroscience Research. 90: 1011-9. PMID 22331573 DOI: 10.1002/jnr.23010  0.56
2012 Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur B. Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62. PMID 22282654 DOI: 10.1158/0008-5472.CAN-11-2526  0.56
2012 Jing X, Wang T, Huang S, Glorioso JC, Albers KM. The transcription factor Sox11 promotes nerve regeneration through activation of the regeneration-associated gene Sprr1a. Experimental Neurology. 233: 221-32. PMID 22024412 DOI: 10.1016/j.expneurol.2011.10.005  0.56
2011 Glorioso JC. Non-coding RNAs and the advent of new directions in therapeutics. Gene Therapy. 18: 1103. PMID 22158030 DOI: 10.1038/gt.2011.150  0.56
2011 Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D, Wolfe D. Gene therapy for pain: results of a phase I clinical trial. Annals of Neurology. 70: 207-12. PMID 21796661 DOI: 10.1002/ana.22446  0.56
2011 Niedernhofer LJ, Glorioso JC, Robbins PD. Dedifferentiation rescues senescence of progeria cells but only while pluripotent. Stem Cell Research & Therapy. 2: 28. PMID 21639955 DOI: 10.1186/scrt69  0.56
2011 Goss JR, Stolz DB, Robinson AR, Zhang M, Arbujas N, Robbins PD, Glorioso JC, Niedernhofer LJ. Premature aging-related peripheral neuropathy in a mouse model of progeria. Mechanisms of Ageing and Development. 132: 437-42. PMID 21596054 DOI: 10.1016/j.mad.2011.04.010  0.56
2011 Goins WF, Krisky DM, Wechuck JB, Wolfe D, Huang S, Glorioso JC. Generation of replication-competent and -defective HSV vectors. Cold Spring Harbor Protocols. 2011: pdb.prot5615. PMID 21536761 DOI: 10.1101/pdb.prot5615  0.56
2011 Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohen JB, Glorioso JC. Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor. Virology. 413: 12-8. PMID 21382632 DOI: 10.1016/j.virol.2011.02.014  0.56
2011 Bernal PJ, Bauer EM, Cao R, Maniar S, Mosher M, Chen J, Wang QJ, Glorioso JC, Pitt BR, Watkins SC, St Croix CM. A role for zinc in regulating hypoxia-induced contractile events in pulmonary endothelium. American Journal of Physiology. Lung Cellular and Molecular Physiology. 300: L874-86. PMID 21378023 DOI: 10.1152/ajplung.00328.2010  0.56
2011 Dmitrieva N, Yu L, Viapiano M, Cripe TP, Chiocca EA, Glorioso JC, Kaur B. Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1362-72. PMID 21177410 DOI: 10.1158/1078-0432.CCR-10-2213  0.56
2011 Goss JR, Cascio M, Goins WF, Huang S, Krisky DM, Clarke RJ, Johnson JW, Yokoyama H, Yoshimura N, Gold MS, Glorioso JC. HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 500-6. PMID 21081904 DOI: 10.1038/mt.2010.246  0.56
2011 Baek H, Uchida H, Jun K, Kim JH, Kuroki M, Cohen JB, Glorioso JC, Kwon H. Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 507-14. PMID 20924362 DOI: 10.1038/mt.2010.207  0.56
2010 Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, Glorioso JC. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection. Journal of Virology. 84: 12200-9. PMID 20861246 DOI: 10.1128/JVI.01633-10  0.56
2010 Miyazato M, Sugaya K, Saito S, Chancellor MB, Goins WF, Goss JR, de Groat WC, Glorioso JC, Yoshimura N. Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats. The Journal of Urology. 184: 1204-10. PMID 20663524 DOI: 10.1016/j.juro.2010.04.066  0.56
2010 Yoshimura N, Kato R, Chancellor MB, Nelson JB, Glorioso JC. Gene therapy as future treatment of erectile dysfunction. Expert Opinion On Biological Therapy. 10: 1305-14. PMID 20662742 DOI: 10.1517/14712598.2010.510510  0.56
2010 Hong CS, Fellows W, Niranjan A, Alber S, Watkins S, Cohen JB, Glorioso JC, Grandi P. Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection. Gene Therapy. 17: 1200-5. PMID 20463757 DOI: 10.1038/gt.2010.66  0.56
2010 Wolfe D, Craft AM, Cohen JB, Glorioso JC. A herpes simplex virus vector system for expression of complex cellular cDNA libraries. Journal of Virology. 84: 7360-8. PMID 20463073 DOI: 10.1128/JVI.02388-09  0.56
2010 Frampton AR, Uchida H, von Einem J, Goins WF, Grandi P, Cohen JB, Osterrieder N, Glorioso JC. Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells. Veterinary Microbiology. 141: 12-21. PMID 19713056 DOI: 10.1016/j.vetmic.2009.07.035  0.56
2009 Yokoyama H, Sasaki K, Franks ME, Goins WF, Goss JR, de Groat WC, Glorioso JC, Chancellor MB, Yoshimura N. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Therapy. 20: 63-71. PMID 20377371 DOI: 10.1089/hum.2008.094  0.56
2009 Goss JR, Gold MS, Glorioso JC. HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain. Gene Therapy. 16: 493-501. PMID 19357694 DOI: 10.1038/gt.2009.24  0.56
2009 Glorioso JC, Fink DJ. Gene therapy for pain: introduction to the special issue. Gene Therapy. 16: 453-4. PMID 19357693 DOI: 10.1038/gt.2009.18  0.56
2009 Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC. Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Review of Neurotherapeutics. 9: 505-17. PMID 19344302 DOI: 10.1586/ern.09.9  0.56
2009 Goins WF, Goss JR, Chancellor MB, de Groat WC, Glorioso JC, Yoshimura N. Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain. Gene Therapy. 16: 558-69. PMID 19242523 DOI: 10.1038/gt.2009.19  0.56
2009 Miyazato M, Sugaya K, Goins WF, Wolfe D, Goss JR, Chancellor MB, de Groat WC, Glorioso JC, Yoshimura N. Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Therapy. 16: 660-8. PMID 19225548 DOI: 10.1038/gt.2009.5  0.56
2009 Uchida H, Shah WA, Ozuer A, Frampton AR, Goins WF, Grandi P, Cohen JB, Glorioso JC. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. Journal of Virology. 83: 2951-61. PMID 19129446 DOI: 10.1128/JVI.01449-08  0.56
2009 Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 13-8. PMID 18841093 DOI: 10.1038/mt.2008.213  0.56
2009 Grant KG, Krisky DM, Ataai MM, Glorioso JC. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Biotechnology and Bioengineering. 102: 1087-97. PMID 18828174 DOI: 10.1002/bit.22123  0.56
2009 Kato R, Wolfe D, Coyle CH, Wechuck JB, Tyagi P, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy. 16: 26-33. PMID 18668142 DOI: 10.1038/gt.2008.132  0.56
2009 Hao S, Wolfe D, Glorioso JC, Mata M, Fink DJ. Effects of transgene-mediated endomorphin-2 in inflammatory pain. European Journal of Pain (London, England). 13: 380-6. PMID 18567517 DOI: 10.1016/j.ejpain.2008.05.008  0.56
2008 Srinivasan R, Wolfe D, Goss J, Watkins S, de Groat WC, Sculptoreanu A, Glorioso JC. Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. The European Journal of Neuroscience. 28: 1241-54. PMID 18973552 DOI: 10.1111/j.1460-9568.2008.06438.x  0.56
2008 Srinivasan R, Fink DJ, Glorioso JC. HSV vectors for gene therapy of chronic pain. Current Opinion in Molecular Therapeutics. 10: 449-55. PMID 18830920  0.56
2008 Craft AM, Krisky DM, Wechuck JB, Lobenhofer EK, Jiang Y, Wolfe DP, Glorioso JC. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles. Stem Cells (Dayton, Ohio). 26: 3119-29. PMID 18787207 DOI: 10.1634/stemcells.2008-0417  0.56
2008 Goins WF, Krisky DM, Wechuck JB, Huang S, Glorioso JC. Construction and production of recombinant herpes simplex virus vectors. Methods in Molecular Biology (Clifton, N.J.). 433: 97-113. PMID 18679619 DOI: 10.1007/978-1-59745-237-3_6  0.56
2008 Li H, Baskaran R, Krisky DM, Bein K, Grandi P, Cohen JB, Glorioso JC. Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth. Virology. 375: 13-23. PMID 18321553 DOI: 10.1016/j.virol.2008.01.038  0.56
2007 McTiernan CF, Mathier MA, Zhu X, Xiao X, Klein E, Swan CH, Mehdi H, Gibson G, Trichel AM, Glorioso JC, Feldman AM, McCurry KR, London B. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts. Gene Therapy. 14: 1613-22. PMID 17851548 DOI: 10.1038/sj.gt.3303020  0.56
2007 Niranjan A, Fellows W, Stauffer W, Burton EA, Hong CS, Lunsford LD, Kondziolka D, Glorioso JC, Gobbel GT. Survival of transplanted neural progenitor cells enhanced by brain irradiation. Journal of Neurosurgery. 107: 383-91. PMID 17695394 DOI: 10.3171/JNS-07/08/0383  0.56
2007 Srinivasan R, Huang S, Chaudhry S, Sculptoreanu A, Krisky D, Cascio M, Friedman PA, de Groat WC, Wolfe D, Glorioso JC. An HSV vector system for selection of ligand-gated ion channel modulators. Nature Methods. 4: 733-9. PMID 17676048 DOI: 10.1038/nmeth1077  0.56
2007 Frampton AR, Stolz DB, Uchida H, Goins WF, Cohen JB, Glorioso JC. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1. Journal of Virology. 81: 10879-89. PMID 17670830 DOI: 10.1128/JVI.00504-07  0.56
2007 Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, Krisky DM, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Therapy. 14: 1344-52. PMID 17611585 DOI: 10.1038/sj.gt.3302990  0.56
2007 Chattopadhyay M, Mata M, Goss J, Wolfe D, Huang S, Glorioso JC, Fink DJ. Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia. 50: 1550-8. PMID 17508196 DOI: 10.1007/s00125-007-0702-4  0.56
2007 Goss JR, Goins WF, Glorioso JC. Gene therapy applications for the treatment of neuropathic pain. Expert Review of Neurotherapeutics. 7: 487-506. PMID 17492900 DOI: 10.1586/14737175.7.5.487  0.56
2007 Hao S, Mata M, Glorioso JC, Fink DJ. Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Therapy. 14: 1010-6. PMID 17443214 DOI: 10.1038/sj.gt.3302950  0.56
2007 Wolfe D, Hao S, Hu J, Srinivasan R, Goss J, Mata M, Fink DJ, Glorioso JC. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain. 133: 29-38. PMID 17395375 DOI: 10.1016/j.pain.2007.02.003  0.56
2007 Tsvitov M, Frampton AR, Shah WA, Wendell SK, Ozuer A, Kapacee Z, Goins WF, Cohen JB, Glorioso JC. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection. Virology. 360: 477-91. PMID 17157347 DOI: 10.1016/j.virol.2006.10.039  0.56
2007 Burton EA, Glorioso JC, Fink DJ. Gene Therapy Approaches in Neurology Molecular Neurology. 101-123. DOI: 10.1016/B978-012369509-3.50009-3  0.56
2007 Burton EA, Glorioso JC. Herpes simplex virus vectors for gene therapy of lysosomal storage disorders Lysosomal Storage Disorders. 111-131. DOI: 10.1007/978-0-387-70909-3_9  0.56
2006 Puskovic V, Wolfe D, Wechuck J, Krisky D, Collins J, Glorioso JC, Fink DJ, Mata M. HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 710-5. PMID 16949343 DOI: 10.1016/j.ymthe.2006.07.004  0.56
2006 Jiang C, Glorioso JC, Ataai M. Presence of imidazole in loading buffer prevents formation of free radical in immobilized metal affinity chromatography and dramatically improves the recovery of herpes simplex virus type 1 gene therapy vectors. Journal of Chromatography. A. 1121: 40-5. PMID 16735041 DOI: 10.1016/j.chroma.2006.04.071  0.56
2006 Jiang C, Ataai M, Ozuer A, Krisky D, Wechuck J, Pornsuwan S, Pourarian F, Glorioso JC. Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnology and Bioengineering. 95: 48-57. PMID 16673413 DOI: 10.1002/bit.20943  0.56
2006 Peng XM, Zhou ZG, Glorioso JC, Fink DJ, Mata M. Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Annals of Neurology. 59: 843-51. PMID 16634039 DOI: 10.1002/ana.20855  0.56
2006 Hong CS, Goins WF, Goss JR, Burton EA, Glorioso JC. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. Gene Therapy. 13: 1068-79. PMID 16541122 DOI: 10.1038/sj.gt.3302719  0.56
2006 Hao S, Mata M, Glorioso JC, Fink DJ. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Molecular Pain. 2: 6. PMID 16503976 DOI: 10.1186/1744-8069-2-6  0.56
2006 Kwon H, Bai Q, Baek HJ, Felmet K, Burton EA, Goins WF, Cohen JB, Glorioso JC. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. Journal of Virology. 80: 138-48. PMID 16352538 DOI: 10.1128/JVI.80.1.138-148.2006  0.56
2006 Mata M, Glorioso JC, Fink DJ. Herpes Simplex Vector-Mediated Gene Transfer to the Peripheral Nervous System for the Treatment of Polyneuropathy and Chronic Pain Gene Therapy of the Central Nervous System: From Bench to Bedside. 209-221. DOI: 10.1016/B978-012397632-1/50017-4  0.56
2005 Kuwayama Y, Suzuki T, Moriuchi S, Glorioso JC, Bessho M. I kappa B-mediated apoptotic gene therapy against acute myelogenous leukemia using replication-defective HSV-1 vector expressing TK and mutant I kappa B alpha. Cellular and Molecular Biology (Noisy-Le-Grand, France). 51: 77-86. PMID 16171566  0.56
2005 Burton EA, Fink DJ, Glorioso JC. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Current Opinion in Molecular Therapeutics. 7: 326-36. PMID 16121698  0.56
2005 Glorioso J, Jacoby J. Interview with David Scadden Gene Therapy. 12: 1663-1666. PMID 16121202 DOI: 10.1038/sj.gt.3302610  0.56
2005 Hao S, Mata M, Wolfe D, Huang S, Glorioso JC, Fink DJ. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Annals of Neurology. 57: 914-8. PMID 15929041 DOI: 10.1002/ana.20483  0.56
2005 Chattopadhyay M, Wolfe D, Mata M, Huang S, Glorioso JC, Fink DJ. Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 307-13. PMID 15927533 DOI: 10.1016/j.ymthe.2005.04.009  0.56
2005 Frampton AR, Goins WF, Nakano K, Burton EA, Glorioso JC. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Therapy. 12: 891-901. PMID 15908995 DOI: 10.1038/sj.gt.3302545  0.56
2005 Chattopadhyay M, Krisky D, Wolfe D, Glorioso JC, Mata M, Fink DJ. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Therapy. 12: 1377-84. PMID 15843809 DOI: 10.1038/sj.gt.3302533  0.56
2005 Bennett NE, Kim JH, Wolfe DP, Sasaki K, Yoshimura N, Goins WF, Huang S, Nelson JB, de Groat WC, Glorioso JC, Chancellor MB. Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. The Journal of Urology. 173: 1820-4. PMID 15821595 DOI: 10.1097/01.ju.0000158056.66236.1f  0.56
2005 Baltimore D. An interview with David Baltimore. [Interview by Joseph Glorioso and Jenny Jacoby]. Gene Therapy. 12: 1291-3. PMID 15815696 DOI: 10.1038/sj.gt.3302526  0.56
2005 Nakano K, Asano R, Tsumoto K, Kwon H, Goins WF, Kumagai I, Cohen JB, Glorioso JC. Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 617-26. PMID 15771964 DOI: 10.1016/j.ymthe.2004.12.012  0.56
2005 Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models. The Journal of Gene Medicine. 7: 638-48. PMID 15754306 DOI: 10.1002/jgm.700  0.56
2005 Frampton AR, Goins WF, Cohen JB, von Einem J, Osterrieder N, O'Callaghan DJ, Glorioso JC. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. Journal of Virology. 79: 3169-73. PMID 15709036 DOI: 10.1128/JVI.79.5.3169-3173.2005  0.56
2005 Moriuchi S, Glorioso JC, Maruno M, Izumoto S, Wolfe D, Huang S, Cohen JB, Yoshimine T. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase. Cancer Gene Therapy. 12: 487-96. PMID 15692608 DOI: 10.1038/sj.cgt.7700816  0.56
2005 Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, Walter M, Roth MG, Lazo JS. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. The Journal of Biological Chemistry. 280: 4079-88. PMID 15557325 DOI: 10.1074/jbc.M411420200  0.56
2005 Fradette J, Wolfe D, Goins WF, Huang S, Flanigan RM, Glorioso JC. HSV vector-mediated transduction and GDNF secretion from adipose cells. Gene Therapy. 12: 48-58. PMID 15470480 DOI: 10.1038/sj.gt.3302359  0.56
2004 Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annual Review of Microbiology. 58: 253-71. PMID 15487938 DOI: 10.1146/annurev.micro.58.030603.123709  0.56
2004 Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, Yoshimura N. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes. 53: 2723-30. PMID 15448108 DOI: 10.2337/diabetes.53.10.2723  0.56
2004 Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe D, Ataai MM, Glorioso JC. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. Journal of Virology. 78: 8994-9006. PMID 15308696 DOI: 10.1128/JVI.78.17.8994-9006.2004  0.56
2004 Wolfe D, Niranjan A, Trichel A, Wiley C, Ozuer A, Kanal E, Kondziolka D, Krisky D, Goss J, Deluca N, Murphey-Corb M, Glorioso JC. Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates. Gene Therapy. 11: 1675-84. PMID 15306839 DOI: 10.1038/sj.gt.3302336  0.56
2004 Puskovic V, Wolfe D, Goss J, Huang S, Mata M, Glorioso JC, Fink DJ. Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 67-75. PMID 15233943 DOI: 10.1016/j.ymthe.2004.04.004  0.56
2004 Liu J, Wolfe D, Hao S, Huang S, Glorioso JC, Mata M, Fink DJ. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 57-66. PMID 15233942 DOI: 10.1016/j.ymthe.2004.04.017  0.56
2004 Trybala E, Olofsson S, MÃ¥rdberg K, Svennerholm B, Umemoto K, Glorioso JC, Bergström T. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Research. 62: 125-34. PMID 15130536 DOI: 10.1016/j.antiviral.2003.12.007  0.56
2004 Wolfe D, Wechuck JB, Krisky DM, Goff JP, Goins WF, Ozuer A, Epperly ME, Greenberger JS, Fink DJ, Glorioso JC. Delivery of herpes simplex virus-based vectors to stem cells. Methods in Molecular Biology (Clifton, N.J.). 246: 339-52. PMID 14970603  0.56
2004 Niranjan A, Wolfe D, Fellows W, Goins WF, Glorioso JC, Kondziolka D, Lunsford LD. Gene transfer to glial tumors using herpes simplex virus. Methods in Molecular Biology (Clifton, N.J.). 246: 323-37. PMID 14970602  0.56
2004 Goss JR, Natsume A, Wolfe D, Mata M, Glorioso JC, Fink DJ. Delivery of herpes simplex virus-based vectors to the nervous system. Methods in Molecular Biology (Clifton, N.J.). 246: 309-22. PMID 14970601  0.56
2004 Goins WF, Wolfe D, Krisky DM, Bai Q, Burton EA, Fink DJ, Glorioso JC. Delivery using herpes simplex virus: an overview. Methods in Molecular Biology (Clifton, N.J.). 246: 257-99. PMID 14970599  0.56
2004 Chattopadhyay M, Goss J, Wolfe D, Goins WC, Huang S, Glorioso JC, Mata M, Fink DJ. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain : a Journal of Neurology. 127: 929-39. PMID 14749293 DOI: 10.1093/brain/awh103  0.56
2004 Mata M, Glorioso JC, Fink DJ. Gene therapy: novel treatments for polyneuropathy and chronic pain. Current Neurology and Neuroscience Reports. 4: 1-2. PMID 14683620  0.56
2003 Natsume A, Wolfe D, Hu J, Huang S, Puskovic V, Glorioso JC, Fink DJ, Mata M. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Experimental Neurology. 184: 878-86. PMID 14769380 DOI: 10.1016/S0014-4886(03)00334-0  0.56
2003 Mata M, Glorioso JC, Fink DJ. Gene transfer to the nervous system: prospects for novel treatments directed at diseases of the aging nervous system. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 58: M1111-8. PMID 14684708  0.56
2003 Glorioso JC, Mata M, Fink DJ. Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors. Expert Opinion On Biological Therapy. 3: 1233-9. PMID 14640949 DOI: 10.1517/14712598.3.8.1233  0.56
2003 Glorioso JC, Mata M, Fink DJ. Gene therapy for chronic pain. Current Opinion in Molecular Therapeutics. 5: 483-8. PMID 14601516  0.56
2003 Mata M, Glorioso J, Fink DJ. Development of HSV-mediated gene transfer for the treatment of chronic pain. Experimental Neurology. 184: S25-9. PMID 14597322 DOI: 10.1016/S0014-4886(03)00357-1  0.56
2003 Fink DJ, Glorioso J, Mata M. Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration. Experimental Neurology. 184: S19-24. PMID 14597321 DOI: 10.1016/S0014-4886(03)00358-3  0.56
2003 Niranjan A, Wolfe D, Tamura M, Soares MK, Krisky DM, Lunsford LD, Li S, Fellows-Mayle W, DeLuca NA, Cohen JB, Glorioso JC. Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 530-42. PMID 14529825 DOI: 10.1016/S1525-0016(03)00232-6  0.56
2003 Hao S, Mata M, Wolfe D, Huang S, Glorioso JC, Fink DJ. HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 367-75. PMID 12946309 DOI: 10.1016/S1525-0016(03)00185-0  0.56
2003 Burton EA, Glorioso JC, Fink DJ. Gene therapy progress and prospects: Parkinson's disease. Gene Therapy. 10: 1721-7. PMID 12939638 DOI: 10.1038/sj.gt.3302116  0.56
2003 Fink D, Mata M, Glorioso JC. Cell and gene therapy in the treatment of pain. Advanced Drug Delivery Reviews. 55: 1055-64. PMID 12935944 DOI: 10.1016/S0169-409X(03)00103-0  0.56
2003 Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, ... ... Glorioso J, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0  0.56
2003 Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nature Reviews. Cancer. 3: 477-88. PMID 12835668 DOI: 10.1038/nrc1122  0.56
2003 Misumi M, Suzuki T, Moriuchi S, Glorioso JC, Bessho M. In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL). Leukemia Research. 27: 695-9. PMID 12801527 DOI: 10.1016/S0145-2126(02)00327-2  0.56
2003 Yao Q, Wang S, Gambotto A, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Therapy. 10: 1055-60. PMID 12776164 DOI: 10.1038/sj.gt.3301881  0.56
2003 Mi Z, Ghivizzani SC, Lechman E, Glorioso JC, Evans CH, Robbins PD. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Research & Therapy. 5: R132-9. PMID 12723985  0.56
2003 Glorioso JC, Mata M, Fink DJ. Therapeutic gene transfer to the nervous system using viral vectors. Journal of Neurovirology. 9: 165-72. PMID 12707847 DOI: 10.1080/13550280390193984  0.56
2003 Hao S, Mata M, Goins W, Glorioso JC, Fink DJ. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain. 102: 135-42. PMID 12620604 DOI: 10.1016/s0304-3959(02)00346-9  0.56
2003 Burton EA, Hong CS, Glorioso JC. The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells. Journal of Virology. 77: 3516-30. PMID 12610127 DOI: 10.1128/JVI.77.6.3516-3530.2003  0.56
2003 Chattopadhyay M, Goss J, Lacomis D, Goins WC, Glorioso JC, Mata M, Fink DJ. Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. The European Journal of Neuroscience. 17: 732-40. PMID 12603263 DOI: 10.1046/j.1460-9568.2003.02500.x  0.56
2003 Guo HL, Wolfe D, Epperly MW, Huang S, Liu K, Glorioso JC, Greenberger J, Blumberg D. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 7: 229-35; discussion 2. PMID 12600447 DOI: 10.1016/S1091-255X(02)00186-5  0.56
2003 Burton EA, Huang S, Goins WF, Glorioso JC. Use of the herpes simplex viral genome to construct gene therapy vectors. Methods in Molecular Medicine. 76: 1-31. PMID 12526156  0.56
2003 Burton EA, Bai Q, Goins WF, Fink DJ, Glorioso JC. Virus-based vectors for gene expression in mammalian cells: Herpes simplex virus New Comprehensive Biochemistry. 38: 27-54. DOI: 10.1016/S0167-7306(03)38003-2  0.56
2002 Goins WF, Marconi P, Krisky D, Wolfe D, Glorioso JC, Ramakrishnan R, Fink DJ. Construction of replication-defective herpes simplex virus vectors. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.11. PMID 18428322 DOI: 10.1002/0471142905.hg1211s33  0.56
2002 Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnology and Bioengineering. 79: 112-9. PMID 17590937 DOI: 10.1002/bit.10310  0.56
2002 Burton EA, Fink DJ, Glorioso JC. Gene delivery using herpes simplex virus vectors. Dna and Cell Biology. 21: 915-36. PMID 12573050 DOI: 10.1089/104454902762053864  0.56
2002 Mata M, Glorioso JC, Fink DJ. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiology & Behavior. 77: 483-8. PMID 12526987 DOI: 10.1016/S0031-9384(02)00908-3  0.56
2002 Burton EA, Bai Q, Goins WF, Glorioso JC. Replication-defective genomic herpes simplex vectors: design and production. Current Opinion in Biotechnology. 13: 424-8. PMID 12459332 DOI: 10.1016/S0958-1669(02)00359-2  0.56
2002 Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Gene Therapy. 9: 1653-8. PMID 12457278 DOI: 10.1038/sj.gt.3301860  0.56
2002 Goss JR, Harley CF, Mata M, O'Malley ME, Goins WF, Hu X, Glorioso JC, Fink DJ. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Annals of Neurology. 52: 662-5. PMID 12402268 DOI: 10.1002/ana.10343  0.56
2002 Campbell NJ, Lemoine NR, Glorioso JC. Information overload? Take the 'Progress and Prospects' cure. Gene Therapy. 9: 1343. PMID 12364998 DOI: 10.1038/sj.gt.3301873  0.56
2002 Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes. 51: 2227-32. PMID 12086954  0.56
2002 Chen XP, Mata M, Kelley M, Glorioso JC, Fink DJ. The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection. Journal of Neurovirology. 8: 204-10. PMID 12053275 DOI: 10.1080/13550280290049642  0.56
2002 Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnology Progress. 18: 476-82. PMID 12052062 DOI: 10.1021/bp010176k  0.56
2002 Goins WF, Krisky DM, Wolfe DP, Fink DJ, Glorioso JC. Development of replication-defective herpes simplex virus vectors. Methods in Molecular Medicine. 69: 481-507. PMID 11987796  0.56
2002 Moriuchi S, Wolfe D, Tamura M, Yoshimine T, Miura F, Cohen JB, Glorioso JC. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Gene Therapy. 9: 584-91. PMID 11973634 DOI: 10.1038/sj.gt.3301693  0.56
2002 Glorioso JC, Fink DJ. Use of HSV vectors to modify the nervous system. Current Opinion in Drug Discovery & Development. 5: 289-95. PMID 11926135  0.56
2002 Iwai M, Harada Y, Ishii M, Kashima K, Mazda O, Tamura M, Wolfe D, Goin WF, Glorioso JC. Suicide gene therapy of human hepatoma and its peritonitis carcinomatosis by a vector of replicative-deficient herpes simplex virus. Biochemical and Biophysical Research Communications. 291: 855-60. PMID 11866443 DOI: 10.1006/bbrc.2002.6524  0.56
2002 Natsume A, Mata M, Wolfe D, Oligino T, Goss J, Huang S, Glorioso J, Fink DJ. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. Journal of Neurotrauma. 19: 61-8. PMID 11852979 DOI: 10.1089/089771502753460240  0.4
2002 Ozuer A, Wechuck JB, Goins WF, Wolfe D, Glorioso JC, Ataai MM. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnology and Bioengineering. 77: 685-92. PMID 11807764 DOI: 10.1002/bit.10162  0.56
2002 Chattopadhyay M, Wolfe D, Huang S, Goss J, Glorioso JC, Mata M, Fink DJ. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Annals of Neurology. 51: 19-27. PMID 11782980 DOI: 10.1002/ana.10061  0.56
2001 Burton EA, Bai Q, Goins WF, Glorioso JC. Targeting gene expression using HSV vectors. Advanced Drug Delivery Reviews. 53: 155-70. PMID 11731025 DOI: 10.1016/S0169-409X(01)00226-5  0.56
2001 Burton EA, Wechuck JB, Wendell SK, Goins WF, Fink DJ, Glorioso JC. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (Dayton, Ohio). 19: 358-77. PMID 11553845 DOI: 10.1634/stemcells.19-5-358  0.56
2001 Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glorioso JC, Comi G, Martino G. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Therapy. 8: 1207-13. PMID 11509953 DOI: 10.1038/sj.gt.3301523  0.56
2001 MÃ¥rdberg K, Trybala E, Glorioso JC, Bergström T. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. The Journal of General Virology. 82: 1941-50. PMID 11458001  0.56
2001 Yao Q, Wang S, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ. Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 901-10. PMID 11407904 DOI: 10.1006/mthe.2001.0343  0.56
2001 Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, Martino G. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Therapy. 8: 13-9. PMID 11402297 DOI: 10.1038/sj.gt.3301357  0.56
2001 Poliani PL, Brok H, Furlan R, Ruffini F, Bergami A, Desina G, Marconi PC, Rovaris M, Uccelli A, Glorioso JC, Penna G, Adorini L, Comi G, 't Hart B, Martino G. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Human Gene Therapy. 12: 905-20. PMID 11387056 DOI: 10.1089/104303401750195872  0.56
2001 Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, Bennett N JR, de Groat WC, Glorioso JC, Chancellor MB. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. The Journal of Urology. 165: 1748-54. PMID 11342969  0.56
2001 Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy. 8: 551-6. PMID 11319622 DOI: 10.1038/sj.gt.3301430  0.56
2001 Burton EA, Glorioso JC. Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors. Drug Discovery Today. 6: 347-356. PMID 11267921 DOI: 10.1016/S1359-6446(01)01713-5  0.56
2001 Ghivizzani SC, Oligino TJ, Glorioso JC, Robbins PD, Evans CH. Direct gene delivery strategies for the treatment of rheumatoid arthritis. Drug Discovery Today. 6: 259-267. PMID 11182599 DOI: 10.1016/S1359-6446(01)01685-3  0.56
2001 Wolfe D, Goins WF, Kaplan TJ, Capuano SV, Fradette J, Murphey-Corb M, Robbins PD, Cohen JB, Glorioso JC. Herpesvirus-mediated systemic delivery of nerve growth factor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 61-9. PMID 11162312 DOI: 10.1006/mthe.2000.0225  0.56
2001 Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature Medicine. 7: 33-40. PMID 11135613 DOI: 10.1038/83324  0.56
2000 Arafat WO, Casado E, Wang M, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT, Gómez-Navarro J. Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 4442-8. PMID 11106265  0.56
2000 Mi Z, Ghivizzani SC, Lechman ER, Jaffurs D, Glorioso JC, Evans CH, Robbins PD. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis and Rheumatism. 43: 2563-70. PMID 11083281 DOI: 10.1002/1529-0131(200011)43:11<2563::AID-ANR25>3.0.CO;2-8  0.56
2000 Rouse RJ, Seifried W, Mistry SK, Goins WF, Glorioso JC. Herpes simplex virus-enhanced cationic lipid/DNA-mediated transfection. Biotechniques. 29: 810-4. PMID 11056812  0.56
2000 Glorioso JC. Perspectives on viral vector design and applications. Advances in Virus Research. 55: 403-7. PMID 11050948  0.56
2000 Ghivizzani SC, Oligino TJ, Glorioso JC, Robbins PD, Evans CH. Gene therapy approaches for treating rheumatoid arthritis. Clinical Orthopaedics and Related Research. S288-99. PMID 11039782  0.56
2000 Chen Xp, Li J, Mata M, Goss J, Wolfe D, Glorioso JC, Fink DJ. Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. Journal of Virology. 74: 10132-41. PMID 11024142 DOI: 10.1128/JVI.74.21.10132-10141.2000  0.56
2000 Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Gene Therapy. 7: 1483-90. PMID 11001368 DOI: 10.1038/sj.gt.3301265  0.56
2000 Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 114-20. PMID 10947938 DOI: 10.1006/mthe.2000.0101  0.56
2000 Glorioso JC, Huang L, Dunbar C, Felgner PL. Highlights from the third annual ASGT meeting. American Society of Gene Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 96-100. PMID 10947934 DOI: 10.1006/mthe.2000.0108  0.56
2000 Marconi P, Tamura M, Moriuchi S, Krisky DM, Niranjan A, Goins WF, Cohen JB, Glorioso JC. Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 1: 71-81. PMID 10933914 DOI: 10.1006/mthe.1999.0008  0.56
2000 Yao Q, Glorioso JC, Evans CH, Robbins PD, Kovesdi I, Oligino TJ, Ghivizzani SC. Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining. The Journal of Gene Medicine. 2: 210-9. PMID 10894267 DOI: 10.1002/(SICI)1521-2254(200005/06)2:3<210::AID-JGM101>3.0.CO;2-P  0.56
2000 Martino G, Poliani PL, Furlan R, Marconi P, Glorioso JC, Adorini L, Comi G. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. Journal of Neuroimmunology. 107: 184-90. PMID 10854655 DOI: 10.1016/S0165-5728(00)00236-8  0.56
2000 Wechuck JB, Goins WF, Glorioso JC, Ataai MM. Effect of protease inhibitors on yield of HSV-1-based viral vectors. Biotechnology Progress. 16: 493-6. PMID 10835254 DOI: 10.1021/bp000016t  0.56
2000 Simonato M, Manservigi R, Marconi P, Glorioso J. Gene transfer into neurones for the molecular analysis of behaviour: Focus on herpes simplex vectors Trends in Neurosciences. 23: 183-190. PMID 10782119 DOI: 10.1016/S0166-2236(99)01539-8  0.56
2000 Gómez-Navarro J, Contreras JL, Arafat W, Jiang XL, Krisky D, Oligino T, Marconi P, Hubbard B, Glorioso JC, Curiel DT, Thomas JM. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Therapy. 7: 43-52. PMID 10680015 DOI: 10.1038/sj.gt.3301054  0.56
2000 Fink DJ, DeLuca NA, Yamada M, Wolfe DP, Glorioso JC. Design and application of HSV vectors for neuroprotection. Gene Therapy. 7: 115-9. PMID 10673716 DOI: 10.1038/sj.gt.3301118  0.56
2000 Anderson DB, Laquerre S, Ghosh K, Ghosh HP, Goins WF, Cohen JB, Glorioso JC. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. Journal of Virology. 74: 2481-7. PMID 10666285 DOI: 10.1128/JVI.74.5.2481-2487.2000  0.56
1999 Akkaraju GR, Huard J, Hoffman EP, Goins WF, Pruchnic R, Watkins SC, Cohen JB, Glorioso JC. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. The Journal of Gene Medicine. 1: 280-9. PMID 10738561 DOI: 10.1002/(SICI)1521-2254(199907/08)1:4<280::AID-JGM45>3.0.CO;2-L  0.56
1999 Oligino T, Ghivizzani SC, Wolfe D, Lechman ER, Krisky D, Mi Z, Evans CH, Robbins PD, Glorioso JC. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis Gene Therapy. 6: 1713-1720. PMID 10516720 DOI: 10.1038/sj.gt.3301014  0.56
1999 Marconi P, Simonato M, Zucchini S, Bregola G, Argnani R, Krisky D, Glorioso JC, Manservigi R. Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Therapy. 6: 904-12. PMID 10505116 DOI: 10.1038/sj.gt.3300882  0.56
1999 Wolfe D, Goins WF, Yamada M, Moriuchi S, Krisky DM, Oligino TJ, Marconi PC, Fink DJ, Glorioso JC. Engineering herpes simplex virus vectors for CNS applications. Experimental Neurology. 159: 34-46. PMID 10486173 DOI: 10.1006/exnr.1999.7158  0.56
1999 Alvira MR, Goins WF, Cohen JB, Glorioso JC. Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection. Journal of Virology. 73: 3866-76. PMID 10196281  0.56
1999 Yamada M, Oligino T, Mata M, Goss JR, Glorioso JC, Fink DJ. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proceedings of the National Academy of Sciences of the United States of America. 96: 4078-83. PMID 10097166 DOI: 10.1073/pnas.96.7.4078  0.56
1999 Whalen JD, Lechman EL, Carlos CA, Weiss K, Kovesdi I, Glorioso JC, Robbins PD, Evans CH. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. Journal of Immunology (Baltimore, Md. : 1950). 162: 3625-32. PMID 10092823  0.56
1999 Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proceedings of the National Academy of Sciences of the United States of America. 96: 3211-6. PMID 10077663 DOI: 10.1073/pnas.96.6.3211  0.56
1999 Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, Glorioso JC. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. Journal of Virology. 73: 519-32. PMID 9847358  0.56
1999 Lemoine NR, Glorioso JC. Gene therapy for the millenium: In with the new Gene Therapy. 6: 1199. DOI: 10.1038/sj.gt.3300984  0.56
1999 Glorioso JC, Schmidt MC. Methods in Enzymology: Preface Methods in Enzymology. 306: xiii. DOI: 10.1016/S0076-6879(99)06001-2  0.56
1998 Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJ, Fink DJ, Glorioso JC. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Therapy. 5: 1593-603. PMID 10023438 DOI: 10.1038/sj.gt.3300766  0.56
1998 Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, Watkins SC, Glorioso JC. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Therapy. 5: 1517-30. PMID 9930305 DOI: 10.1038/sj.gt.3300755  0.56
1998 Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Cancer Research. 58: 5731-7. PMID 9865731  0.56
1998 Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy. Biochemical and Biophysical Research Communications. 252: 686-90. PMID 9837767 DOI: 10.1006/bbrc.1998.9685  0.56
1998 Wang M, Rancourt C, Navarro JG, Krisky D, Marconi P, Oligino T, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT. High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector. Gynecologic Oncology. 71: 278-87. PMID 9826472 DOI: 10.1006/gyno.1998.5132  0.56
1998 Laquerre S, Anderson DB, Stolz DB, Glorioso JC. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. Journal of Virology. 72: 9683-97. PMID 9811702  0.56
1998 Laquerre S, Argnani R, Anderson DB, Zucchini S, Manservigi R, Glorioso JC. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. Journal of Virology. 72: 6119-30. PMID 9621076  0.56
1998 Oligino T, Poliani PL, Wang Y, Tsai SY, O'Malley BW, Fink DJ, Glorioso JC. Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Therapy. 5: 491-6. PMID 9614573 DOI: 10.1038/sj.gt.3300612  0.56
1998 Kang W, Wilson MA, Bender MA, Glorioso JC, Wilson SP. Herpes virus-mediated preproenkephalin gene transfer to the amygdala is antinociceptive. Brain Research. 792: 133-5. PMID 9593860 DOI: 10.1016/S0006-8993(98)00194-2  0.56
1998 Laquerre S, Anderson DB, Argnani R, Glorioso JC. Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. Journal of Virology. 72: 4940-9. PMID 9573262  0.56
1997 Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Therapy. 4: 1120-5. PMID 9415320 DOI: 10.1038/sj.gt.3300497  0.4
1997 Rasty S, Poliani PL, Fink DJ, Glorioso JC. Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. Journal of Neurovirology. 3: 247-64. PMID 9291233  0.56
1997 Glorioso JC, Goins WF, Schmidt MC, Oligino T, Krisky DM, Marconi PC, Cavalcoli JD, Ramakrishnan R, Poliani PL, Fink DJ. Engineering herpes simplex virus vectors for human gene therapy. Advances in Pharmacology (San Diego, Calif.). 40: 103-36. PMID 9217925 DOI: 10.1016/S1054-3589(08)60139-8  0.56
1997 Goins WF, Krisky D, Marconi P, Oligino T, Ramakrishnan R, Poliani PL, Fink DJ, Glorioso JC. Herpes simplex virus vectors for gene transfer to the nervous system. Journal of Neurovirology. 3: S80-8. PMID 9179803  0.56
1997 Fink DJ, Poliani PL, Oligino T, Krisky DM, Goins WF, Glorioso JC. Development of an HSV-based vector for the treatment of Parkinson's disease. Experimental Neurology. 144: 103-21. PMID 9126159 DOI: 10.1006/exnr.1996.6395  0.56
1997 Fink DJ, Glorioso JC. Engineering herpes simplex virus vectors for gene transfer to neurons. Nature Medicine. 3: 357-9. PMID 9055868 DOI: 10.1038/nm0397-357  0.56
1997 Huard J, Akkaraju G, Watkins SC, Pike-Cavalcoli M, Glorioso JC. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Human Gene Therapy. 8: 439-52. PMID 9054519 DOI: 10.1089/hum.1997.8.4-439  0.56
1997 Fink DJ, Glorioso JC. Herpes simplex virus-based vectors: problems and some solutions. Advances in Neurology. 72: 149-56. PMID 8993694  0.56
1996 Oligino T, Poliani PL, Marconi P, Bender MA, Schmidt MC, Fink DJ, Glorioso JC. In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16. Gene Therapy. 3: 892-9. PMID 8908503  0.56
1996 Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF, Fink DJ, Glorioso JC. Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proceedings of the National Academy of Sciences of the United States of America. 93: 11319-20. PMID 8876133 DOI: 10.1073/pnas.93.21.11319  0.56
1996 Fink DJ, DeLuca NA, Goins WF, Glorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Annual Review of Neuroscience. 19: 265-87. PMID 8833444 DOI: 10.1146/annurev.ne.19.030196.001405  0.56
1996 Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Human Gene Therapy. 7: 1261-80. PMID 8793551 DOI: 10.1089/hum.1996.7.10-1261  0.56
1996 Soares K, Hwang DY, Ramakrishnan R, Schmidt MC, Fink DJ, Glorioso JC. cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. Journal of Virology. 70: 5384-94. PMID 8764049  0.4
1996 Ramakrishnan R, Poliani PL, Levine M, Glorioso JC, Fink DJ. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. Journal of Virology. 70: 6519-23. PMID 8709293  0.56
1995 Fink DJ, Ramakrishnan R, Marconi P, Goins WF, Holland TC, Glorioso JC. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system. Clinical Neuroscience (New York, N.Y.). 3: 284-91. PMID 8914795  0.4
1995 Glorioso JC, DeLuca NA, Fink DJ. Development and application of herpes simplex virus vectors for human gene therapy. Annual Review of Microbiology. 49: 675-710. PMID 8561476 DOI: 10.1146/annurev.mi.49.100195.003331  0.56
1995 Glorioso JC, Bender MA, Goins WF, Fink DJ, DeLuca N. HSV as a gene transfer vector for the nervous system. Molecular Biotechnology. 4: 87-99. PMID 8521042 DOI: 10.1007/BF02907473  0.56
1995 Chase GA, DeLeon PA, Dronamraju KR, Erickson RP, Glorioso JC, Hirschhorn R, Lysaught MT, McGraw KM, Meyers AS, Miller AD. Regulation of human gene therapy. Science (New York, N.Y.). 269: 14-5. PMID 7604272  0.56
1995 Huard J, Goins WF, Glorioso JC. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Therapy. 2: 385-92. PMID 7584113  0.56
1994 Glorioso JC, Goins WF, DeLuca N, Fink DJ. Development of herpes simplex virus as a gene transfer vector for the nervous system. Gene Therapy. 1: S39. PMID 8542392  0.56
1994 Glorioso JC, Goins WF, Meaney CA, Fink DJ, DeLuca NA. Gene transfer to brain using herpes simplex virus vectors. Annals of Neurology. 35: S28-34. PMID 8185293 DOI: 10.1002/ana.410350710  0.56
1994 Goins WF, Sternberg LR, Croen KD, Krause PR, Hendricks RL, Fink DJ, Straus SE, Levine M, Glorioso JC. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. Journal of Virology. 68: 2239-52. PMID 8139009  0.56
1994 Ramakrishnan R, Fink DJ, Jiang G, Desai P, Glorioso JC, Levine M. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. Journal of Virology. 68: 1864-73. PMID 8107247  0.56
1994 Glorioso JC, Goins WF, Fink DJ, DeLuca NA. Herpes simplex virus vectors and gene transfer to brain. Developments in Biological Standardization. 82: 79-87. PMID 7958486  0.56
1993 Desai P, Ramakrishnan R, Lin ZW, Osak B, Glorioso JC, Levine M. The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection. Journal of Virology. 67: 6125-35. PMID 8396674  0.56
1993 Gage PJ, Levine M, Glorioso JC. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. Journal of Virology. 67: 2191-201. PMID 8383236 DOI: 10.1128/jvi.67.4.2191-2201.1993  0.56
1993 Desai P, DeLuca NA, Glorioso JC, Person S. Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. Journal of Virology. 67: 1357-64. PMID 8382300  0.56
1993 Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 90: 10764-8. PMID 8248169  0.56
1992 Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH. Gene transfer to synoviocytes: prospects for gene treatment of arthritis. Dna and Cell Biology. 11: 227-31. PMID 1567555  0.56
1992 Dolter KE, Goins WF, Levine M, Glorioso JC. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. Journal of Virology. 66: 4864-73. PMID 1378512  0.56
1992 Gage PJ, Sauer B, Levine M, Glorioso JC. A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. Journal of Virology. 66: 5509-15. PMID 1323709 DOI: 10.1128/jvi.66.9.5509-5515.1992  0.56
1992 Fink DJ, Sternberg LR, Weber PC, Mata M, Goins WF, Glorioso JC. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Human Gene Therapy. 3: 11-9. PMID 1314100 DOI: 10.1089/hum.1992.3.1-11  0.4
1991 Highlander SL, Goins WF, Person S, Holland TC, Levine M, Glorioso JC. Oligomer formation of the gB glycoprotein of herpes simplex virus type 1. Journal of Virology. 65: 4275-83. PMID 1649330  0.56
1990 Kimmel KA, Dolter KE, Toth GM, Levine M, Glorioso JC. Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C. Journal of Virology. 64: 4033-6. PMID 2164613  0.56
1990 Muggeridge MI, Wu TT, Johnson DC, Glorioso JC, Eisenberg RJ, Cohen GH. Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology. 174: 375-87. PMID 2154881 DOI: 10.1016/0042-6822(90)90091-5  0.56
1990 Weber PC, Levine M, Glorioso JC. Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes. Journal of Virology. 64: 300-6. PMID 2152818  0.56
1990 Levine M, Krikos A, Glorioso JC, Homa FL. Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Advances in Experimental Medicine and Biology. 278: 151-64. PMID 1963032 DOI: 10.1007/978-1-4684-5853-4_16  0.56
1990 Wu CT, Levine M, Homa F, Highlander SL, Glorioso JC. Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. Journal of Virology. 64: 856-63. PMID 1688628 DOI: 10.1128/jvi.64.2.856-863.1990  0.56
1989 Weber PC, Levine M, Glorioso JC. A rapid and sensitive method for plasmid copy number comparisons. Nucleic Acids Research. 17: 5866. PMID 2668898  0.56
1989 Chrisp CE, Sunstrum JC, Averill DR, Levine M, Glorioso JC. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence. Laboratory Investigation; a Journal of Technical Methods and Pathology. 60: 822-30. PMID 2543866  0.56
1989 Highlander SL, Dorney DJ, Gage PJ, Holland TC, Cai W, Person S, Levine M, Glorioso JC. Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration. Journal of Virology. 63: 730-8. PMID 2463380 DOI: 10.1128/jvi.63.2.730-738.1989  0.56
1988 Sunstrum JC, Chrisp CE, Levine M, Glorioso JC. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system. Virus Research. 11: 17-32. PMID 2845681  0.56
1988 Huff V, Cai W, Glorioso JC, Levine M. The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles. Journal of Virology. 62: 4403-6. PMID 2845151  0.56
1988 Weber PC, Levine M, Glorioso JC. Simple assay for quantitation of Tn5 inversion events in Escherichia coli and use of the assay in determination of plasmid copy number. Journal of Bacteriology. 170: 4972-5. PMID 2844732  0.56
1988 Muggeridge MI, Isola VJ, Byrn RA, Tucker TJ, Minson AC, Glorioso JC, Cohen GH, Eisenberg RJ. Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants. Journal of Virology. 62: 3274-80. PMID 2841479  0.56
1988 Weber PC, Challberg MD, Nelson NJ, Levine M, Glorioso JC. Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell. 54: 369-81. PMID 2840204 DOI: 10.1016/0092-8674(88)90200-0  0.56
1988 Homa FL, Glorioso JC, Levine M. A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes & Development. 2: 40-53. PMID 2833425 DOI: 10.1101/gad.2.1.40  0.56
1988 Highlander SL, Cai WH, Person S, Levine M, Glorioso JC. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. Journal of Virology. 62: 1881-8. PMID 2452895  0.56
1987 Robbins AK, Dorney DJ, Wathen MW, Whealy ME, Gold C, Watson RJ, Holland LE, Weed SD, Levine M, Glorioso JC. The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. Journal of Virology. 61: 2691-701. PMID 3039163  0.56
1987 Weber PC, Levine M, Glorioso JC. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science (New York, N.Y.). 236: 576-9. PMID 3033824  0.56
1987 Shapira M, Homa FL, Glorioso JC, Levine M. Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Research. 15: 3097-111. PMID 3031620 DOI: 10.1093/nar/15.7.3097  0.56
1987 Kikuchi GE, Baker SA, Merajver SD, Coligan JE, Levine M, Glorioso JC, Nairn R. Purification and structural characterization of herpes simplex virus glycoprotein C. Biochemistry. 26: 424-31. PMID 3030409  0.56
1987 Bishop GA, McCurry L, Schwartz SA, Glorioso JC. Activation of human natural killer cells by herpes simplex virus type 1-infected cells. Intervirology. 28: 78-88. PMID 2832348 DOI: 10.1159/000149999  0.56
1987 Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, Glorioso JC. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Journal of Virology. 61: 3356-64. PMID 2444713 DOI: 10.1128/jvi.61.11.3356-3364.1987  0.56
1986 Homa FL, Otal TM, Glorioso JC, Levine M. Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Molecular and Cellular Biology. 6: 3652-66. PMID 3025606 DOI: 10.1128/MCB.6.11.3652  0.56
1986 Friedman HM, Glorioso JC, Cohen GH, Hastings JC, Harris SL, Eisenberg RJ. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. Journal of Virology. 60: 470-5. PMID 3021981  0.56
1986 Homa FL, Purifoy DJ, Glorioso JC, Levine M. Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. Journal of Virology. 58: 281-9. PMID 3009845 DOI: 10.1128/jvi.58.2.281-289.1986  0.56
1986 Marlin SD, Highlander SL, Holland TC, Levine M, Glorioso JC. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. Journal of Virology. 59: 142-53. PMID 2423702  0.56
1986 Bishop GA, Kümel G, Schwartz SA, Glorioso JC. Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. Journal of Virology. 57: 294-300. PMID 2416952  0.56
1985 Goldin AL, Sandri-Goldin RM, Glorioso JC, Levine M. Stable induction of a 51K cellular protein in neuronal cells surviving herpes simplex virus type 1 infection. Virology. 142: 398-405. PMID 2997992 DOI: 10.1016/0042-6822(85)90347-2  0.56
1985 Marlin SD, Holland TC, Levine M, Glorioso JC. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. Journal of Virology. 53: 128-36. PMID 2578193  0.56
1985 Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. Journal of Virology. 56: 930-7. PMID 2415719  0.56
1984 Glorioso J, Schröder CH, Kumel G, Szczesiul M, Levine M. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity. Journal of Virology. 50: 805-12. PMID 6328010 DOI: 10.1128/JVI.50.3.805-812.1984  0.56
1984 Sandri-Goldin RM, Goldin AL, Glorioso J, Levine M. Herpes simplex virus thymidine kinase gene is stably maintained and expressed in cells transformed by protoplast fusion. Somatic Cell and Molecular Genetics. 10: 129-38. PMID 6324392 DOI: 10.1007/BF01534902  0.56
1984 Holland LE, Sandri-Goldin RM, Goldin AL, Glorioso JC, Levine M. Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. Journal of Virology. 49: 947-59. PMID 6199514  0.56
1984 Kikuchi GE, Coligan JE, Holland TC, Levine M, Glorioso JC, Nairn R. Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules. Journal of Virology. 52: 806-15. PMID 6092712  0.56
1984 Holland TC, Homa FL, Marlin SD, Levine M, Glorioso J. Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. Journal of Virology. 52: 566-74. PMID 6092678 DOI: 10.1128/jvi.52.2.566-574.1984  0.56
1983 Sandri-Goldin RM, Goldin AL, Levine M, Glorioso J. High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion. Methods in Enzymology. 101: 402-11. PMID 6350818  0.56
1983 Sandri-Goldin RM, Goldin AL, Holland LE, Glorioso JC, Levine M. Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Molecular and Cellular Biology. 3: 2028-44. PMID 6318078  0.56
1983 Holland TC, Sandri-Goldin RM, Holland LE, Marlin SD, Levine M, Glorioso JC. Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay. Journal of Virology. 46: 649-52. PMID 6302327  0.56
1983 Bishop GA, Glorioso JC, Schwartz SA. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. The Journal of Experimental Medicine. 157: 1544-61. PMID 6189940  0.56
1983 Glorioso J, Szczesiul MS, Marlin SD, Levine M. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane. Virology. 126: 1-18. PMID 6189286 DOI: 10.1016/0042-6822(83)90458-0  0.56
1981 Sandri-Goldin RM, Goldin AL, Levine M, Glorioso JC. High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Molecular and Cellular Biology. 1: 743-52. PMID 9279387  0.56
1981 Goldin AL, Sandri-Goldin RM, Levine M, Glorioso JC. Cloning of herpes simplex virus type 1 sequences representing the whole genome. Journal of Virology. 38: 50-8. PMID 6264114  0.56
1981 Sandri-Goldin RM, Levine M, Glorioso JC. Method for induction of mutations in physically defined regions of the herpes simplex virus genome. Journal of Virology. 38: 41-9. PMID 6264113  0.56
1980 Glorioso JC, Levine M, Holland TC, Szczesiul MS. Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis. Journal of Virology. 35: 672-81. PMID 6252331  0.56
1980 Levine M, Goldin AL, Glorioso JC. Persistence of herpes simplex virus genes in cells of neuronal origin. Journal of Virology. 35: 203-10. PMID 6251268  0.56
1978 Adler R, Glorioso JC, Levine M. Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction. The Journal of General Virology. 39: 9-20. PMID 205630  0.56
1978 Adler R, Glorioso JC, Cossman J, Levine M. Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infection and Immunity. 21: 442-7. PMID 80379  0.56
Show low-probability matches.